Ligand Pharmaceuticals Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2014-12-31 3 months ending 2014-09-30 6 months ending 2014-06-30 3 months ending 2014-03-31 3 months ending 2013-12-31
Revenue 23.00 14.97 26.57 15.96 14.74
Other Revenue, Total - - - - -
Total Revenue 23.00 14.97 26.57 15.96 14.74
Cost of Revenue, Total 4.00 1.50 3.64 2.45 1.32
Gross Profit 19.00 13.48 22.93 13.51 13.42
Selling/General/Admin. Expenses, Total 5.52 6.74 10.31 5.07 4.42
Research & Development 3.28 3.02 5.82 3.13 2.37
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) 0.56 0.18 0.34 0.20 0.20
Other Operating Expenses, Total - - - - -
Total Operating Expense 13.36 11.44 20.11 10.86 8.31
Operating Income 9.64 3.53 6.46 5.10 6.42
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net 0.29 -1.11 -2.64 -2.70 -4.10
Income Before Tax 7.01 0.90 3.39 2.15 2.01
Income After Tax 6.73 0.78 3.38 2.10 1.87
Minority Interest 0.32 0.50 0.31 0.00 -
Equity In Affiliates - - - - -
Net Income Before Extra. Items 7.05 1.28 3.69 2.10 1.87
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income 7.05 1.28 3.69 2.10 1.87
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items 7.05 1.28 3.69 2.10 1.87
Income Available to Common Incl. Extra Items 7.05 1.28 3.69 2.10 1.87
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - - - 0.00 -
Diluted Weighted Average Shares 20.84 21.35 21.49 21.78 21.29
Diluted EPS Excluding Extraordinary Items 0.34 0.06 0.17 0.10 0.09
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue - 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS 0.36 0.07 0.19 0.11 0.10